Colgate-Palmolive Company $CL is GUARDCAP ASSET MANAGEMENT Ltd’s 7th Largest Position

GUARDCAP ASSET MANAGEMENT Ltd reduced its position in Colgate-Palmolive Company (NYSE:CL) by 9.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,515,478 shares of the company’s stock after selling 365,019 shares during the period. Colgate-Palmolive accounts for about 6.5% of GUARDCAP ASSET MANAGEMENT Ltd’s investment portfolio, making the stock its 7th biggest position. GUARDCAP ASSET MANAGEMENT Ltd owned about 0.43% of Colgate-Palmolive worth $281,027,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of CL. Westside Investment Management Inc. increased its holdings in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares during the last quarter. Vermillion & White Wealth Management Group LLC raised its holdings in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares during the period. Copia Wealth Management bought a new stake in Colgate-Palmolive in the third quarter worth $29,000. Cloud Capital Management LLC purchased a new position in Colgate-Palmolive during the third quarter worth $30,000. Finally, MTM Investment Management LLC bought a new position in Colgate-Palmolive during the second quarter valued at $39,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. UBS Group lifted their price target on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Citigroup increased their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. Morgan Stanley upped their price objective on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $94.00 price target on shares of Colgate-Palmolive in a report on Saturday, January 31st. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.47.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $94.18 on Tuesday. The company has a market capitalization of $75.92 billion, a PE ratio of 35.95, a P/E/G ratio of 4.26 and a beta of 0.29. The company has a 50-day simple moving average of $82.41 and a two-hundred day simple moving average of $81.59. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the previous year, the firm earned $0.91 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. Research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The SEC filing for this sale provides additional information. 0.41% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.